Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis
Arthritis & Rheumatology · 2026
DOI: 10.1002/art.43315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Viola Pitkänen und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Arthritis, Juvenile, Chromatin, Antibodies, Antinuclear, Autoantibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lastentautien Tutkimussäätiö, Päivikki ja Sakari Sohlbergin Säätiö, ISLAB Laboratory Centre.
Abstract (Originalsprache)
Objective
Patients with juvenile idiopathic arthritis (JIA) frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in patients with JIA remains elusive.
Methods
Plasma samples from 110 untreated patients with active JIA, as well as from 14 children with unspecified arthritis and 151 age‐ and sex‐matched healthy children, were analyzed with multiple modern clinical‐grade autoantibody assays, including automated indirect immunofluorescence to screen for ANAs with HEp‐2 cells, and specific immune assays to detect reactivity to individual autoantigens. In addition, a HuProt proteome microarray was used to screen for novel autoantibody targets in plasma samples from five patients with ANA‐positive JIA and four ANA‐negative healthy controls.
Results
Homogeneous nuclear ANA staining, indicating reactivity toward chromatin, was detected in most (61.8%) patients with JIA but rarely in healthy controls (2.6%; P < 0.0001). No antibody reactivity to specific nuclear antigens or other autoantigens associated with connective tissue diseases was detected. However, 20% of patients with JIA harbored antibodies against double‐stranded DNA (dsDNA)–nucleosome complexes (compared with 2.6% of controls, P < 0.0001). Finally, the proteome microarray revealed core histone H2A variant H2AFY, part of the nucleosome, to be the most widely recognized human protein by autoantibodies of patients with JIA.
Conclusion
Autoantibody reactivity in JIA primarily targets chromatin, but the epitopes targeted are likely either posttranslationally modified or multimolecule epitopes, such as dsDNA–nucleosome complexes, rather than epitopes on individual native proteins or purified dsDNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Eastern Finland, Kuopio, Finland.
- Kuopio University Hospital, Kuopio.
- Oulu University Hospital and University of Oulu, Oulu, Finland.
- University of Turku and Turku University Hospital, Turku, Finland.
- Tampere University Hospital, Tampere, and University of Helsinki, Helsinki, Finland.
- University of Turku, Turku, Finland.
ORCID-Profile: Tuure Kinnunen
Förderung
- Lastentautien Tutkimussäätiö
- Päivikki ja Sakari Sohlbergin Säätiö
- ISLAB Laboratory Centre
Zitieren
APA
Pitkänen, V., Remes-Pakarinen, T., Vähäsalo, P., Möttönen, M., Grönlund, M. M., Arvonen, M., Knip, M., Veijola, R., Toppari, J., Ilonen, J., Lempainen, J., Schroderus, A. M., Kröger, L., & Kinnunen, T. (2026). Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43315
Vancouver
Pitkänen V, Remes-Pakarinen T, Vähäsalo P, Möttönen M, Grönlund MM, Arvonen M, et al. Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. 2026. doi:10.1002/art.43315
BibTeX
@article{Pitknen2026,
author = {Pitkänen, Viola and Remes-Pakarinen, Terhi and Vähäsalo, Paula and Möttönen, Milja and Grönlund, Minna-Maija and Arvonen, Miika and Knip, Mikael and Veijola, Riitta and Toppari, Jorma and Ilonen, Jorma and Lempainen, Johanna and Schroderus, Anna-Mari and Kröger, Liisa and Kinnunen, Tuure},
title = {Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis},
journal = {Arthritis & Rheumatology},
year = {2026},
doi = {10.1002/art.43315}
}
EUVIMED